Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo
- PMID: 20828398
- PMCID: PMC2945978
- DOI: 10.1186/1756-9966-29-123
Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo
Abstract
Background: RhoA and RhoC have been proved to be over-expressed in many solid cancers, including colorectal cancer. The reduction of RhoA and RhoC expression by RNA interference (RNAi) resulted growth inhibition of cancer cells. The present study was to evaluate the effect of silencing of RhoA and RhoC expression by RNAi on growth of human colorectal carcinoma (CRC) in tumor-bearing nude mice in vivo.
Methods: To establish HCT116 cell transplantable model, the nude mice were subcutaneously inoculated with 1.0 × 10(7) HCT116 cells and kept growing till the tumor xenografts reached 5-7 mm in diameter. Then the mice were randomly assigned to three groups(seven mice in each group): (1) normal saline(NS) group, (2)replication-defective recombinant adenovirus carrying the negative control shRNA (Ad-HK) group and (3)replication-defective recombinant adenovirus carrying the 4-tandem linked RhoA and RhoC shRNAs (Ad-RhoA-RhoC) group. Ad-HK (4 × 10(8) pfu, 30 ul/mouse), Ad-RhoA-RhoC (4 × 10(8) pfu, 30 ul/mouse) or PBS (30 ul/mouse) was injected intratumorally four times once every other day. The weight and volumes of tumor xenografts were recorded. The levels of RhoA and RhoC mRNA transcripts and proteins in tumor xenografts were detected by reverse quantitative transcription polymerase chain reaction (QRT-PCR) and immunohistochemical staining respectively. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay was used to detect the death of cells.
Results: The xenografts in mice could be seen at 5th day from the implantation of HCT116 cells and all had reached 5-7 mm in size at 9th day. After injection intratumorally, the growth speed of tumor xenografts in Ad-RhoA-RhoC group was significantly delayed compared with those in NS and Ad-HK group(P < 0.05). The results of QRT-PCR showed that mRNA levels of RhoA and RhoC reduced more in Ad-RhoA-RhoC group than those in NS and Ad-HK group. The relative RhoA and RhoC mRNA transcripts were decreased to 48% and 43% respectively (P < 0.05). Immunohistochemical analyses of tumor xenograft sections also revealed the decreased RhoA and RhoC expression in Ad-RhoA-RhoC group. TUNEL assay also showed higher death of tumor xenograft tissue cells in Ad-RhoA-RhoC group.
Conclusion: Recombinant adenovirus mediated RhoA and RhoC shRNA in tandem linked expression may inhibit the growth of human colorectal tumor xenografts in vivo. These results indicate that RhoA and RhoC might be potential targets for gene therapy in colorectal cancer.
Figures






Similar articles
-
Inhibitory effects of adenovirus mediated tandem expression of RhoA and RhoC shRNAs in HCT116 cells.J Exp Clin Cancer Res. 2009 Apr 18;28(1):52. doi: 10.1186/1756-9966-28-52. J Exp Clin Cancer Res. 2009. PMID: 19374769 Free PMC article.
-
[Effect and mechanism of gene therapy of lentivirus mediated RhoA shRNA on ovarian cancer xenograft in vivo].Zhonghua Fu Chan Ke Za Zhi. 2013 Oct;48(10):778-83. Zhonghua Fu Chan Ke Za Zhi. 2013. PMID: 24406137 Chinese.
-
RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway.World J Gastroenterol. 2007 Jul 7;13(25):3517-22. doi: 10.3748/wjg.v13.i25.3517. World J Gastroenterol. 2007. PMID: 17659701 Free PMC article.
-
Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma.Lab Invest. 2003 Jun;83(6):861-70. doi: 10.1097/01.lab.0000073128.16098.31. Lab Invest. 2003. PMID: 12808121
-
RhoA, RhoB and RhoC have different roles in cancer cell migration.J Microsc. 2013 Sep;251(3):242-9. doi: 10.1111/jmi.12025. Epub 2013 Mar 12. J Microsc. 2013. PMID: 23488932 Review.
Cited by
-
Knockdown a water channel protein, aquaporin-4, induced glioblastoma cell apoptosis.PLoS One. 2013 Aug 12;8(8):e66751. doi: 10.1371/journal.pone.0066751. eCollection 2013. PLoS One. 2013. PMID: 23950863 Free PMC article.
-
MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA.Oncotarget. 2017 Feb 28;8(9):14887-14896. doi: 10.18632/oncotarget.14841. Oncotarget. 2017. PMID: 28146427 Free PMC article.
-
Rho GTPases as Key Molecular Players within Intestinal Mucosa and GI Diseases.Cells. 2021 Jan 4;10(1):66. doi: 10.3390/cells10010066. Cells. 2021. PMID: 33406731 Free PMC article. Review.
-
Rho GTPase isoforms in cell motility: Don't fret, we have FRET.Cell Adh Migr. 2014;8(6):526-34. doi: 10.4161/cam.29712. Cell Adh Migr. 2014. PMID: 25482645 Free PMC article. Review.
-
Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways.Biosci Rep. 2020 Mar 27;40(3):BSR20200265. doi: 10.1042/BSR20200265. Biosci Rep. 2020. PMID: 32149326 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous